9341 Stock Overview
Engages in the medical platform and smart clinic businesses in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
GENOVA, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥942.00 |
| 52 Week High | JP¥1,975.00 |
| 52 Week Low | JP¥806.00 |
| Beta | -0.49 |
| 1 Month Change | -7.56% |
| 3 Month Change | -28.91% |
| 1 Year Change | -27.54% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -45.77% |
Recent News & Updates
Recent updates
GENOVA, Inc. (TSE:9341) Might Not Be As Mispriced As It Looks After Plunging 26%
Mar 12
Concerns Surrounding GENOVA's (TSE:9341) Performance
Nov 21Investors Give GENOVA, Inc. (TSE:9341) Shares A 29% Hiding
Aug 05These 4 Measures Indicate That GENOVA (TSE:9341) Is Using Debt Safely
Aug 03What You Can Learn From GENOVA, Inc.'s (TSE:9341) P/E
Jun 21GENOVA's (TSE:9341) Solid Earnings Have Been Accounted For Conservatively
May 21Shareholder Returns
| 9341 | JP Healthcare Services | JP Market | |
|---|---|---|---|
| 7D | 15.2% | 5.0% | -0.3% |
| 1Y | -27.5% | -15.4% | -10.2% |
Return vs Industry: 9341 underperformed the JP Healthcare Services industry which returned -15.4% over the past year.
Return vs Market: 9341 underperformed the JP Market which returned -10.2% over the past year.
Price Volatility
| 9341 volatility | |
|---|---|
| 9341 Average Weekly Movement | 7.9% |
| Healthcare Services Industry Average Movement | 7.6% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in JP Market | 9.2% |
| 10% least volatile stocks in JP Market | 2.9% |
Stable Share Price: 9341's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 9341's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 404 | n/a | www.genova.co.jp |
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital.
GENOVA, Inc. Fundamentals Summary
| 9341 fundamental statistics | |
|---|---|
| Market cap | JP¥16.02b |
| Earnings (TTM) | JP¥1.87b |
| Revenue (TTM) | JP¥10.19b |
8.7x
P/E Ratio1.6x
P/S RatioIs 9341 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9341 income statement (TTM) | |
|---|---|
| Revenue | JP¥10.19b |
| Cost of Revenue | JP¥2.60b |
| Gross Profit | JP¥7.59b |
| Other Expenses | JP¥5.73b |
| Earnings | JP¥1.87b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 14, 2025
| Earnings per share (EPS) | 107.78 |
| Gross Margin | 74.51% |
| Net Profit Margin | 18.30% |
| Debt/Equity Ratio | 0.5% |
How did 9341 perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 12:03 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
GENOVA, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.